IκBNS inhibits induction of a subset of toll-like receptor-dependent genes and limits inflammation

被引:120
作者
Kuwata, H
Matsumoto, M
Atarashi, K
Morishita, H
Hirotani, T
Koga, R
Takeda, K
机构
[1] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Higashi Ku, Fukuoka 8128582, Japan
[2] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka 5650871, Japan
关键词
D O I
10.1016/j.immuni.2005.11.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-like receptor (TLR)-mediated immune responses are downregulated by several mechanisms that affect signaling pathways. However, it remains elusive how TLR-mediated gene expression is differentially modulated. Here, we show that I kappa BNS, a TLR-inducible nuclear I kappa B protein, negatively regulates induction of a subset of TLR-dependent genes through inhibition of NF-kappa B activity. I kappa BNS-deficient macrophages and dendritic cells show increased TLR-mediated expression of genes such as IL-6 and IL-12p40, which are induced late after TLR stimulation. In contrast, I kappa BNS-deficient cells showed normal induction of genes that are induced early or induced via IRF-3 activation. LPS stimulation of I kappa BNS-deficient macrophages prolonged NF-kappa B activity at the specific promoters, indicating that I kappa BNS mediates termination of NF-kappa B activity at selective gene promoters. Moreover, I kappa BNS-deficient mice are highly susceptible to LPS-induced endotoxin shock and intestinal inflammation. Thus, I kappa BNS regulates inflammatory responses by inhibiting the induction of a subset of TLR-dependent genes through modulation of NF-kappa B activity.
引用
收藏
页码:41 / 51
页数:11
相关论文
共 44 条
[1]   Toll-like receptor signalling [J].
Akira, S ;
Takeda, K .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :499-511
[2]   MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis [J].
Araki, A ;
Kanai, T ;
Ishikura, T ;
Makita, S ;
Uraushihara, K ;
Iiyama, R ;
Totsuka, T ;
Takeda, K ;
Akira, S ;
Watanabe, M .
JOURNAL OF GASTROENTEROLOGY, 2005, 40 (01) :16-23
[3]   Inferences, questions and possibilities in toll-like receptor signalling [J].
Beutler, B .
NATURE, 2004, 430 (6996) :257-263
[4]   Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways [J].
Björkbacka, H ;
Kunjathoor, VV ;
Moore, KJ ;
Koehn, S ;
Ordija, CM ;
Lee, MA ;
Means, T ;
Halmen, K ;
Luster, AD ;
Golenbock, DT ;
Freeman, MW .
NATURE MEDICINE, 2004, 10 (04) :416-421
[5]   The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses [J].
Boone, DL ;
Turer, EE ;
Lee, EG ;
Ahmad, RC ;
Wheeler, MT ;
Tsui, C ;
Hurley, P ;
Chien, M ;
Chai, S ;
Hitotsumatsu, O ;
McNally, E ;
Pickart, C ;
Ma, A .
NATURE IMMUNOLOGY, 2004, 5 (10) :1052-1060
[6]   ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance [J].
Brint, EK ;
Xu, DM ;
Liu, HY ;
Dunne, A ;
McKenzie, ANJ ;
O'Neill, LAJ ;
Liew, FY .
NATURE IMMUNOLOGY, 2004, 5 (04) :373-379
[7]   Inhibition of interleukin 1 receptor/toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4 [J].
Burns, K ;
Janssens, S ;
Brissoni, B ;
Olivos, N ;
Beyaert, R ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) :263-268
[8]   Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors [J].
Chuang, TH ;
Ulevitch, RJ .
NATURE IMMUNOLOGY, 2004, 5 (05) :495-502
[9]   TRAIL-R as a negative regulator of innate immune cell responses [J].
Diehl, GE ;
Yue, HH ;
Hsieh, K ;
Kuang, AA ;
Ho, M ;
Morici, LA ;
Lenz, LL ;
Cado, D ;
Riley, LW ;
Winoto, A .
IMMUNITY, 2004, 21 (06) :877-889
[10]   Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105 [J].
Divanovic, S ;
Trompette, A ;
Atabani, SF ;
Madan, R ;
Golenbock, DT ;
Visintin, A ;
Finberg, RW ;
Tarakhovsky, A ;
Vogel, SN ;
Belkaid, Y ;
Kurt-Jones, EA ;
Karp, CL .
NATURE IMMUNOLOGY, 2005, 6 (06) :571-578